ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Artemis Medicare Services Earnings Call: Key Takeaways

Artemis Medicare delivered a solid FY26 with 15.4% revenue growth, driven by core specialties and improved case mix. Management is aggressively expanding bed capacity from 800 to 2,000 by 2029.

Highlights
Revenue growth15.4% YoY revenue growth reached INR 1,081 crore in FY26.
MarginsEBITDA margins stable at 20.2%; expecting slight compression during new launches.
Demand visibilityStrong demand for specialized services like oncology and organ transplants.
Management confidenceBalanced confidence despite geographic concentration and geopolitical headwinds in international segments.

Growth

15.4% YoY revenue growth; PAT up 26.2% despite West Asian geopolitical impacts on international patient traffic.

Outlook

Raipur facility operational Q1 FY27; South Delhi by FY29; targeting 2,000 beds by 2029.

Risks

EBITDA drag from upcoming Raipur facility; reliance on international patients (31% of revenue) amid global instability.

Source

Earnings Call filed with BSE, NSE: ARTEMISMED. Summary written with AI assistance from the document.

Read the document ↗

Artemis Medicare Services Ltd: key numbers

Share price
₹313.50
Market cap
₹4,963 Cr
Revenue (annual)
₹1,081 Cr
Net profit (annual)
₹103.6 Cr
P/E (TTM)
43.3×Sector 54.5×
Promoter holding
58.39%+0.00% QoQ
FII holding
12.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Artemis Medicare Services Ltd

All →